These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1294 related articles for article (PubMed ID: 29579146)
1. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy. Wu HY; Cao CY Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146 [TBL] [Abstract][Full Text] [Related]
2. Applications and advances of CRISPR-Cas9 in cancer immunotherapy. Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486 [TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment. Mollanoori H; Shahraki H; Rahmati Y; Teimourian S Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221 [TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review. Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803 [TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges. Yi L; Li J Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687 [TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591 [TBL] [Abstract][Full Text] [Related]
7. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9. Ren J; Zhao Y Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148 [TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 technology as a potent molecular tool for gene therapy. Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 therapies in experimental mouse models of cancer. Estêvão D; Rios Costa N; da Costa RG; Medeiros R Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767 [TBL] [Abstract][Full Text] [Related]
10. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management. Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042 [TBL] [Abstract][Full Text] [Related]
11. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy. Zhang X; Cheng C; Sun W; Wang H Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential. Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool. Shojaei Baghini S; Gardanova ZR; Abadi SAH; Zaman BA; İlhan A; Shomali N; Adili A; Moghaddar R; Yaseri AF Cell Mol Biol Lett; 2022 May; 27(1):35. PubMed ID: 35508982 [TBL] [Abstract][Full Text] [Related]
14. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications. Liu C; Zhang L; Liu H; Cheng K J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805 [TBL] [Abstract][Full Text] [Related]
15. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910 [TBL] [Abstract][Full Text] [Related]
16. [Research progress of CRISPR-Cas9 system for gene therapy]. Zhan C; Xia X Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy. Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410 [TBL] [Abstract][Full Text] [Related]
18. Development and application of CRISPR/Cas9 technologies in genomic editing. Zhang C; Quan R; Wang J Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic applications of CRISPR/Cas9 system in gene therapy. Mollanoori H; Teimourian S Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220 [TBL] [Abstract][Full Text] [Related]
20. Advances in therapeutic application of CRISPR-Cas9. Sun J; Wang J; Zheng D; Hu X Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]